DALLAS, March 20, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

Candel Therapeutics (CADL) together with IDEA Pharma announced a strategic commercial partnership. Under this agreement, IDEA will provide strategic commercial input throughout the development and ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

DALLAS, March 20, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

Under the agreement, Servier will develop and commercialize BDTX-4933, a small molecule designed by Black Diamond Therapeutics for RAF/RAS-mutant solid tumors. Under the terms of the deal ...

My wife and I would both be dead, but for what many derisively call “Big Pharma.” My wife has a rare, genetic form of stage four lung cancer for which there is no cure. Her lungs are filled ...

Skyhawk Therapeutics is a clinical-stage biotechnology ... Skyhawk has built collaborations with multiple pharma partners that leverage Skyhawk's novel platform across disease areas including ...

“Ireland has our pharma companies,” said US president Donald Trump on Wednesday in some of the most significant comments of his encounter with Taoiseach Micheál Martin. And he wants them bac ...

Laurence is an accomplished biotech entrepreneur, serving multiple C-Suite roles throughout his 30 years of experience in the pharma and ... as CEO at Decibel Therapeutics (acquired by Regeneron ...

Viking Therapeutics' stock declined by 37% following ... With an unlimited amount of resources, "big pharma" can offer volume-based rebates and patient support programs that are difficult for ...